Events calendar

Upcoming important dates in our investor calendar.

Review of bepirovirsen Phase III data presented at EASL

28 May 2026

Following EASL on 28th May, we are hosting a call with Nina Mojas, President, Global Product Strategy, Kaivan Khavandi, SVP, R&D Head Respiratory, Immunology & Inflammation, Melanie Paff, VP, MDL HBV Program and Prof Seng Gee Lim, Director of Hepatology, National University Health System, Singapore, highlighting our data from the B-Well 1 and B-Well 2 phase III pivotal studies on Thursday, 28 May 2026 at 3:00 pm BST / 10:00 am EDT (60 minutes).

All events

2026

28
May

Review of bepirovirsen Phase III data presented at EASL

03
Jun

Jefferies Global Healthcare Conference

Hesham Abdullah, SVP, Global Oncology R&D, will participate at the Jefferies Global Healthcare Conference in New York on Wednesday, 3 June 2026.

03
Jun

BNP Paribas Exane CEO Conference

Julie Brown, Chief Financial Officer, will attend the BNP Paribas Exane CEO Conference in Paris on Wednesday, 3 June 2026.

10
Jun

Citi European Healthcare CEO Conference

Luke Miels, Chief Executive Officer, will attend the Citi European Healthcare CEO Conference in London on Wednesday, 10 June 2026.

28
Jul

Quarterly results

We will announce our second quarter results and update on portfolio growth opportunities on Tuesday, 28 July 2026. We will host an in-person and webcast event in London for investors and analysts at 2:00 PM BST | 9:00 AM EDT.

28
Oct

Quarterly results

We will announce our third quarter results on Wednesday, 28 October 2026.

2027

03
Feb

Quarterly results

We will announce our full year and fourth quarter results on Wednesday, 3 February 2027.

Past event materials

Search through our archives of speeches and presentations and past quarterly results announcements, both dating back to 2010, as well as the archive of the Annual and Corporate Responsibility reports dating back to 2000.